Intelligent Bio Solutions Files 8-K
Ticker: INBS · Form: 8-K · Filed: Dec 3, 2024 · CIK: 1725430
Sentiment: neutral
Topics: 8-K, disclosure, filing
TL;DR
IBSI filed a standard 8-K, no major news.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on December 3, 2024, primarily for Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates routine corporate reporting by Intelligent Bio Solutions Inc. to the SEC, ensuring transparency for investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosure and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- INTELLIGENT BIO SOLUTIONS INC. (company) — Registrant
- 001-39825 (company) — SEC File Number
- 135 West, 41st Street , 5th Floor New York , NY 10036 (company) — Principal executive offices address
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing for Intelligent Bio Solutions Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on December 3, 2024.
What is the exact name of the company filing this report?
The exact name of the company is INTELLIGENT BIO SOLUTIONS INC.
What is the state of incorporation for Intelligent Bio Solutions Inc.?
The state of incorporation for Intelligent Bio Solutions Inc. is Delaware.
What were the previous names of Intelligent Bio Solutions Inc.?
The previous names of Intelligent Bio Solutions Inc. were GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc.
Filing Stats: 500 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-12-03 17:15:38
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 29KB
- ex99-1_001.jpg (GRAPHIC) — 241KB
- ex99-1_002.jpg (GRAPHIC) — 384KB
- ex99-1_003.jpg (GRAPHIC) — 198KB
- ex99-1_004.jpg (GRAPHIC) — 187KB
- ex99-1_005.jpg (GRAPHIC) — 153KB
- ex99-1_006.jpg (GRAPHIC) — 118KB
- ex99-1_007.jpg (GRAPHIC) — 184KB
- ex99-1_008.jpg (GRAPHIC) — 165KB
- ex99-1_009.jpg (GRAPHIC) — 152KB
- ex99-1_010.jpg (GRAPHIC) — 182KB
- ex99-1_011.jpg (GRAPHIC) — 204KB
- ex99-1_012.jpg (GRAPHIC) — 233KB
- ex99-1_013.jpg (GRAPHIC) — 162KB
- ex99-1_014.jpg (GRAPHIC) — 145KB
- ex99-1_015.jpg (GRAPHIC) — 282KB
- ex99-1_016.jpg (GRAPHIC) — 198KB
- ex99-1_017.jpg (GRAPHIC) — 146KB
- ex99-1_018.jpg (GRAPHIC) — 180KB
- ex99-1_019.jpg (GRAPHIC) — 196KB
- ex99-1_020.jpg (GRAPHIC) — 131KB
- ex99-1_021.jpg (GRAPHIC) — 204KB
- ex99-1_022.jpg (GRAPHIC) — 140KB
- ex99-1_023.jpg (GRAPHIC) — 197KB
- 0001493152-24-048518.txt ( ) — 6276KB
- inbs-20241203.xsd (EX-101.SCH) — 3KB
- inbs-20241203_lab.xml (EX-101.LAB) — 33KB
- inbs-20241203_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 3, 2024 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer